Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
HIV Med ; 20(2): 88-98, 2019 02.
Article in English | MEDLINE | ID: mdl-30474908

ABSTRACT

OBJECTIVES: Selection as a consequence of volunteer participation in, and loss to follow-up from, cohort studies may bias estimates of mortality and other health outcomes. To quantify this potential, we estimated mortality and health service use among people living with HIV (PLWH) who were lost to cohort follow-up (LTCFU) from a volunteer clinical HIV-infected cohort, and compared these to mortality and health service use in active cohort participants and non-cohort-participants living with HIV in Ontario, Canada. METHODS: We analysed population-based provincial health databases from 1995 to 2014, identifying PLWH ≥ 18 years old; these included data from participants in the Ontario HIV Treatment Network Cohort Study (OCS), a volunteer, multi-site clinical HIV-infected cohort. We calculated all-cause mortality, hospitalization and emergency department (ED) visit rates per 100 person-years (PY) and estimated hazard ratios (HRs) of mortality, adjusting for age, sex, income, rurality, and immigration status. RESULTS: Among 23 043 PLWH, 5568 were OCS participants. Compared with nonparticipants, participants were younger and less likely to be female, to be an immigrant and to reside in a major urban centre, and had lower comorbidity. Mortality among active participants, participants LTCFU and nonparticipants was 2.52, 3.30 and 2.20 per 100 PY, respectively. After adjustment for covariates, mortality risk was elevated among participants LTCFU compared with active participants (HR 2.26; 95% confidence interval 1.91, 2.68). Age-adjusted hospitalization rates and ED visit rates were highest among participants LTCFU. CONCLUSIONS: Mortality risk and use of health care resources were lower among active cohort participants. Our findings may inform health outcome estimates based on volunteer cohorts, as well as quantitative bias adjustment to correct for such biases.


Subject(s)
Emigrants and Immigrants/statistics & numerical data , HIV Infections/mortality , Hospitalization/statistics & numerical data , Adult , Databases, Factual , Emergency Service, Hospital , Female , Humans , Lost to Follow-Up , Male , Middle Aged , Mortality , Ontario , Retrospective Studies , Socioeconomic Factors , Young Adult
2.
HIV Med ; 20(2): 110-120, 2019 02.
Article in English | MEDLINE | ID: mdl-30430742

ABSTRACT

OBJECTIVES: Timely HIV diagnosis and presentation to medical care are important for treatment and prevention. Our objective was to measure late diagnosis, delayed presentation and late presentation among individuals in the Ontario HIV Treatment Network Cohort Study (OCS) who were newly diagnosed in Ontario. METHODS: The OCS is a multi-site clinical cohort study of people living with HIV in Ontario, Canada. We measured prevalence of late diagnosis [CD4 count < 350 cells/µL or an AIDS-defining condition (ADC) within 3 months of HIV diagnosis], delayed presentation (≥ 3 months from HIV diagnosis to presentation to care), and late presentation (CD4 count < 350 cells/µL or ADC within 3 months of presentation). We identified characteristics associated with these outcomes and explored their overlap. RESULTS: A total of 1819 OCS participants were newly diagnosed in Ontario from 1999 to 2013. Late diagnosis (53.0%) and presentation (54.0%) were common, and a quarter (23.1%) of participants were delayed presenters. In multivariable models, the participants of delayed presentation decreased over calendar time, but that of late diagnosis/presentation did not. Late diagnosis contributed to the majority (> 87%) of late presentation, and the prevalence of delayed presentation was similar among those diagnosed late versus early (13.4 versus 13.4%, respectively; P = 0.99). Characteristics associated with higher odds of late diagnosis/presentation in multivariable analyses included older age at diagnosis/presentation; African, Caribbean and Black race/ethnicity; Indigenous race/ethnicity; female sex; and being a male who did not report sex with men. There were lower odds of late diagnosis/presentation among participants who had ever injected drugs. In contrast, delayed presentation risk factors included younger age at diagnosis and having ever injected drugs. CONCLUSIONS: Late presentation is common in Ontario, as it is in other high-income countries. Our findings suggest that efforts to reduce late presentation should focus on facilitating earlier diagnosis for the populations identified in this analysis.


Subject(s)
Delayed Diagnosis/statistics & numerical data , HIV Infections/diagnosis , Time-to-Treatment/statistics & numerical data , Adult , CD4 Lymphocyte Count , Cohort Studies , Early Diagnosis , Female , HIV Infections/immunology , Humans , Male , Middle Aged , Multivariate Analysis , Ontario/epidemiology , Prevalence
3.
HIV Med ; 18(9): 655-666, 2017 10.
Article in English | MEDLINE | ID: mdl-28440036

ABSTRACT

OBJECTIVES: We sought to compare all-cause mortality of people living with HIV and accessing care in Canada and the UK. METHODS: Individuals from the Canadian Observational Cohort (CANOC) collaboration and UK Collaborative HIV Cohort (UK CHIC) study who were aged ≥ 18 years, had initiated antiretroviral therapy (ART) for the first time between 2000 and 2012 and who had acquired HIV through sexual transmission were included in the analysis. Cox regression was used to investigate the difference in mortality risk between the two cohort collaborations, accounting for loss to follow-up as a competing risk. RESULTS: A total of 19 960 participants were included in the analysis (CANOC, 4137; UK CHIC, 15 823). CANOC participants were more likely to be older [median age 39 years (interquartile range (IQR): 33, 46 years) vs. 36 years (IQR: 31, 43 years) for UK CHIC participants], to be male (86 vs. 73%, respectively), and to report men who have sex with men (MSM) sexual transmission risk (72 vs. 56%, respectively) (all P < 0.001). Overall, 762 deaths occurred during 98 798 person-years (PY) of follow-up, giving a crude mortality rate of 7.7 per 1000 PY [95% confidence interval (CI): 7.1, 8.3 per 1000 PY]. The crude mortality rates were 8.6 (95% CI: 7.4, 10.0) and 7.5 (95% CI: 6.9, 8.1) per 1000 PY among CANOC and UK CHIC study participants, respectively. No statistically significant difference in mortality risk was observed between the cohort collaborations in Cox regression accounting for loss to follow-up as a competing risk (adjusted hazard ratio 0.86; 95% CI: 0.72-1.03). CONCLUSIONS: Despite differences in national HIV care provision and treatment guidelines, mortality risk did not differ between CANOC and UK CHIC study participants who acquired HIV through sexual transmission.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , HIV Infections/mortality , Adult , Canada/epidemiology , Cohort Studies , Female , Humans , Male , Middle Aged , Observational Studies as Topic , Risk Factors , Sexually Transmitted Diseases, Viral/drug therapy , Sexually Transmitted Diseases, Viral/mortality , United Kingdom/epidemiology
4.
Bone Marrow Transplant ; 51(6): 841-7, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26926230

ABSTRACT

Although neurocognitive impairment has been established as a major issue among cancer survivors, the real-world consequences of this impairment are unclear. This study investigated the relationship between neurocognitive functioning and medication management ability over time among 58 patients treated with allogeneic hematopoietic stem cell transplantation (HCT). Participants completed a neuropsychological test battery and a simulated medication management task at three time points: pre-transplant (T0), Day 100 (T1) and 6 months post transplant (T2). Neurocognitively impaired participants performed worse on the medication management task than neurocognitively normal participants at each time point, and were more likely to score in the impaired range of medication management ability post transplant (72% vs 20%, P<0.001 at T1; 67% vs 23%, P=0.013 at T2). In multivariate analyses, worse performance in executive functioning/working memory consistently predicted impaired medication management ability, even when controlling for sociodemographic and clinical confounders (odds ratio=0.89, 95% confidence interval (0.80, 0.98), P=0.023). Lower physical symptom distress also predicted impaired medication management ability, but this effect decreased over time. Self-reported cognitive problems were not correlated with medication management ability at any time point. Findings suggest that poor neurocognitive functioning, particularly in the domain of executive functioning/working memory, is associated with worse medication management ability within the first 6 months after allogeneic HCT.


Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Neuropsychological Tests , Self Care/psychology , Adolescent , Adult , Aged , Cognition Disorders/etiology , Executive Function , Female , Humans , Male , Medication Adherence/psychology , Medication Therapy Management , Memory, Short-Term , Middle Aged , Survivors/psychology , Young Adult
6.
Acta Psychiatr Scand ; 131(4): 256-68, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25604122

ABSTRACT

OBJECTIVE: This study examines neurocognitive functioning in a large, well-characterized sample of homeless adults with mental illness and assesses demographic and clinical factors associated with neurocognitive performance. METHOD: A total of 1500 homeless adults with mental illness enrolled in the At Home Chez Soi study completed neuropsychological measures assessing speed of information processing, memory, and executive functioning. Sociodemographic and clinical data were also collected. Linear regression analyses were conducted to examine factors associated with neurocognitive performance. RESULTS: Approximately half of our sample met criteria for psychosis, major depressive disorder, and alcohol or substance use disorder, and nearly half had experienced severe traumatic brain injury. Overall, 72% of participants demonstrated cognitive impairment, including deficits in processing speed (48%), verbal learning (71%) and recall (67%), and executive functioning (38%). The overall statistical model explained 19.8% of the variance in the neurocognitive summary score, with reduced neurocognitive performance associated with older age, lower education, first language other than English or French, Black or Other ethnicity, and the presence of psychosis. CONCLUSION: Homeless adults with mental illness experience impairment in multiple neuropsychological domains. Much of the variance in our sample's cognitive performance remains unexplained, highlighting the need for further research in the mechanisms underlying cognitive impairment in this population.


Subject(s)
Cognition Disorders/epidemiology , Ill-Housed Persons/psychology , Mental Disorders/psychology , Adult , Alcoholism/complications , Brain Injuries/complications , Canada/epidemiology , Cognition , Cognition Disorders/etiology , Cross-Sectional Studies , Depressive Disorder, Major/complications , Female , Humans , Linear Models , Male , Mental Disorders/complications , Middle Aged , Models, Statistical , Neuropsychological Tests , Psychotic Disorders/complications , Stress Disorders, Post-Traumatic/complications , Substance-Related Disorders/complications
7.
Can Commun Dis Rep ; 41(12): 322-326, 2015 Dec 03.
Article in English | MEDLINE | ID: mdl-29769926

ABSTRACT

There is new hope that we can significantly reduce HIV rates. The United Nations AIDS organization, UNAIDS, has challenged all countries to strive for aggressive targets that could significantly bend the curve on HIV infections and deaths: 90% of people living with HIV diagnosed; 90% of people diagnosed on treatment; and 90% of people on treatment virally suppressed. This new optimism is largely driven by strong research findings that early and ongoing HIV treatment improves individual health outcomes and reduces people's viral load, making them less infectious. However, the risk of HIV infection is far from evenly distributed among populations most at risk. Those most at risk will find it hardest to reach these targets as they are caught in a syndemic (synergistic epidemic) of intertwining health and social issues. Our research, and that of others, shows that those who are in a syndemic of co-occurring mental health, addiction and social issues (e.g. homelessness, food insecurity) are significantly more likely to fall out of care, less likely to adhere to treatment and less likely to achieve/maintain an undetectable viral load. Intervention studies have found that a combination approach to HIV prevention and treatment that goes beyond primary care and mental health tools to include social and structural interventions has a protective effect, and can reduce risk and improve adherence. People living with and at risk of HIV need better access to social and mental health services as well as clinical treatment services that will help them achieve and maintain optimal health and well-being. We strongly encourage those in the HIV sector across the country to identify a common vision, with clear goals and targets. With concerted and targeted efforts, a focus on program and implementation science, and a willingness to see and treat HIV as a social as well as a biomedical problem-the fourth decade of HIV in Canada could well be the last.

8.
Ann Oncol ; 25(12): 2404-2412, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25214544

ABSTRACT

BACKGROUND: Cognitive impairment and fatigue have been associated with cancer and its treatment. We present baseline data from a large longitudinal study that evaluates cognitive function, fatigue, and potential underlying mechanisms following diagnosis of colorectal cancer (CRC). PATIENTS AND METHODS: We evaluated CRC patients with stage I-III disease before or after surgery, participants with limited metastatic disease and healthy controls (HC). Neuropsychological evaluation included clinical and computerised tests. Participants completed questionnaires for fatigue and quality of life (QOL)-(FACT-F), anxiety/depression, and cognitive symptoms (FACT-Cog). Ten cytokines, clotting factors, sex hormones, carcinoembryonic antigen (CEA), and apolipoprotein E genotype were evaluated. Primary end points were cognitive function on clinical tests evaluated by a Global Deficit score (GDS) and fatigue. Associations between test results, demographic, and disease related factors were explored. RESULTS: We assessed 291 participants with early-stage disease [median age 59 (23-75) years, 63% men], 72 with metastatic disease, and 72 HC. Using GDS, 45% (126/281) of participants with early-stage CRC had cognitive impairment versus 15% (11/72) of HC (odds ratio 4.51, 95% confidence interval 2.28-8.93; P < 0.001), with complex processing speed, attention/working memory, and verbal learning efficiency being most affected. Women with early-stage CRC had greater cognitive impairment than men [55/105 (52%) versus 71/176 (40%), P < 0.050]. Cognitive symptoms were self-reported by 21% (59/286) of early-stage patients versus 17% (12/72) of HC; fatigue by 52% (149/287) of early-stage patients and 26% (19/72) of HC (P < 0.0001). Women reported more fatigue than men (P = 0.003). Fatigue, QOL, anxiety/depression, and cognitive symptoms were associated with each other (r = 0.43-0.71), but not with neuropsychological performance. Most cytokines were elevated in cancer patients. Cognitive function was not associated with cytokines, sex hormones, clotting factors, CEA, or apolipoprotein E genotype. CONCLUSIONS: The incidence of cognitive impairment was three to five times higher in CRC patients than HC, with women having higher impairment rates than men. The cognitive impairment profile suggests dysfunction primarily in fronto-subcortical brain systems. TRIAL REGISTRATION: NCT00188331.


Subject(s)
Cognition , Colorectal Neoplasms/diagnosis , Fatigue , Adult , Aged , Colorectal Neoplasms/physiopathology , Colorectal Neoplasms/psychology , Female , Humans , Longitudinal Studies , Male , Middle Aged , Neuropsychological Tests , Young Adult
9.
HIV Clin Trials ; 13(2): 90-102, 2012.
Article in English | MEDLINE | ID: mdl-22510356

ABSTRACT

BACKGROUND: The influence of chronic hepatitis C virus (HCV) infection on the risk, timing, and type of AIDS-defining illnesses (ADIs) is not well described. To this end, rates of ADIs were evaluated in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy (HAART). METHODS: ADIs were classified into 6 Centers for Disease Control and Prevention (CDC)-defined etiological subgroups: non-Hodgkin lymphoma, viral infection, bacterial infection, HIV-related disease, protozoal infection, and mycotic infection. Generalized estimating equation (GEE) Poisson regression models were used to estimate the effect of HCV on rates of ADIs after adjusting for covariates. RESULTS: Among 2,706 HAART recipients, 768 (28%) were HCV coinfected. Rates of all ADIs combined and of bacterial infection, HIV-related disease, and mycotic infection were increased in HCV-coinfected persons and among those with CD4 counts <200 cells/mm3 HCV was associated with an increased risk of ADIs (rate ratio [RR], 1.38; 95% CI, 1.01-1.88) and a 2-fold increased risk of mycotic infections (RR, 2.21; 95% CI, 1.35-3.62) in univariate analyses and after adjusting for age, baseline viral load, baseline CD4 count, and region of Canada. However, after further adjustment for HAART interruptions, HCV was no longer associated with an increased rate of ADIs overall (RR, 1.13; 95% CI, 0.80-1.59), but remained associated with an increased rate of mycotic infections (RR, 1.97, 95% CI, 1.08-3.61). CONCLUSION: Although HCV coin-fected individuals are at increased risk of developing ADIs overall, our analysis suggests that behavioral variables associated with HCV (including rates of retention on HAART), and not biological interactions with HCV itself, are primarily responsible.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/drug therapy , Antiretroviral Therapy, Highly Active , HIV Infections/complications , HIV Infections/drug therapy , Hepatitis C, Chronic/complications , Adult , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/therapeutic use , Canada/epidemiology , Cohort Studies , Coinfection , Female , HIV Infections/epidemiology , Hepatitis C, Chronic/epidemiology , Humans , Male , Middle Aged
10.
HIV Med ; 12(6): 352-60, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21059167

ABSTRACT

OBJECTIVE: The aim of the study was to evaluate time to virological suppression in a cohort of individuals who started highly active antiretroviral therapy (HAART), and to explore the factors associated with suppression. METHODS: Eligible participants were HIV-positive individuals from a multi-site Canadian cohort of antiretroviral-naïve patients initiating HAART on or after 1 January 2000. Viral load and CD4 measurements within 6 months prior to HAART initiation were assessed. Univariate and multivariate analyses were conducted using piecewise survival exponential models where time scale was divided into intervals (<10 months; ≥10 months). Virological suppression was defined as the time to the first of at least two consecutive viral load measurements <50 HIV-1 RNA copies/mL. RESULTS: A total of 3555 individuals were included in the study, of median age 40 years [interquartile range (IQR) 34-47 years]. Eighty per cent were male, 18% had a history of injecting drug use (IDU), and 13% presented with an AIDS-defining illness at baseline. The median time to suppression was 4.55 months (IQR 2.99-7.89 months). In multivariate analyses, older age, male sex, treatment in Ontario rather than British Columbia, non-IDU history, and having an AIDS diagnosis at baseline predicted increased likelihood of suppression. Patients with low baseline viral load were more likely to have suppression [4-5 log(10) copies/mL, hazard ratio (HR) 1.27, 95% confidence interval (CI) 1.18-1.38; <4 log(10) copies/mL, HR 1.49, 95% CI 1.32-1.68] than patients with baseline viral load ≥5 log(10) copies/mL; however, this effect ceased after 18 months of follow-up. Suppression was more likely with nonnucleoside reverse transcriptase inhibitors and ritonavir-boosted HAART. CONCLUSION: Identification of patients at risk for diminished likelihood of virological suppression will allow focusing of efforts and the utilization of resources to maximize the benefits of HAART.


Subject(s)
HIV Infections/immunology , HIV-1/immunology , RNA, Viral/immunology , Adult , Antiretroviral Therapy, Highly Active/methods , CD4 Lymphocyte Count , Canada/epidemiology , Cohort Studies , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , Humans , Male , Middle Aged , RNA, Viral/drug effects , Treatment Outcome , Viral Load
11.
AIDS Care ; 20(6): 615-24, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18576163

ABSTRACT

Drawing on the Greater Involvement of People with HIV/AIDS (GIPA) principle, the HIV/AIDS movement began to "democratize" research in Canada in the mid-1990s. To date, there is little evidence about the success of the community-based research (CBR) movement in relation to the implementation of GIPA. We draw on findings from a larger study examining barriers and facilitating factors in relation to HIV-related CBR in Ontario, Canada. An online survey was completed by 39 senior managers in Ontario AIDS service organizations (ASOs). Twenty-five in-depth, semi-structured interviews were then conducted to further explore the survey findings. Survey respondents reported that, compared to researchers and frontline service providers, people living with HIV/AIDS (PLWHA) tended to be the least involved in all stages (input, process and outcome) of CBR projects. AIDS service organizations with a mandate that included serving rural and urban communities reported even lower levels of PLWHA involvement in CBR. Qualitative data reveal complex barriers that make meaningful PLWHA engagement in CBR difficult, including: HIV-related stigma; health-related challenges; "credentialism"; lack of capacity to engage in research; other issues taking priority; and mistrust of researchers. Facilitating factors included valuing lived experience; training and mentoring opportunities; financial compensation; trust building; and accommodating PLWHA's needs. While there is strong support for the GIPA principles in theory, practice lags far behind.


Subject(s)
Community Health Services/standards , HIV Infections/psychology , HIV-1 , Patient Participation , Program Development/methods , Program Evaluation , Acquired Immunodeficiency Syndrome/psychology , Female , Health Knowledge, Attitudes, Practice , Humans , Male , Ontario , Patient Acceptance of Health Care/psychology , Prejudice , Research Design , Research Personnel/organization & administration , Truth Disclosure
13.
Cochrane Database Syst Rev ; (3): CD001442, 2006 Jul 19.
Article in English | MEDLINE | ID: mdl-16855968

ABSTRACT

BACKGROUND: Adherence to prescribed regimens is required to derive maximal benefit from many highly active antiretroviral therapy (HAART) regimens in people living with HIV/AIDS. OBJECTIVES: To conduct a systematic review of the research literature on the effectiveness of patient support and education to improve adherence to HAART. SEARCH STRATEGY: A systematic search of electronic databases was performed from January 1996 to May 2005. SELECTION CRITERIA: Randomized controlled trials examining the effectiveness of patient support and education to improve adherence to HAART were considered for inclusion. Only those studies that measured adherence at a minimum of six weeks were included. DATA COLLECTION AND ANALYSIS: Study selection, quality assessments and data abstraction were performed independently by two reviewers. MAIN RESULTS: Nineteen studies involving a total of 2,159 participants met criteria for inclusion. It was not possible to conduct a meta-analysis due to study heterogeneity with respect to populations, interventions, comparison groups, outcomes, and length of follow-up. Sample sizes ranged from 22 to 367. The populations studied ranged from general HIV-positive populations to studies focusing exclusively on children, women, Latinos, or adults with a history of alcohol dependence, to studies focusing almost exclusively on men. Study interventions included cognitive behavioral therapy, motivational interviewing, medication management strategies, and interventions indirectly targeting adherence, such as programs directed to reduce risky sexual behaviours. Ten studies demonstrated a beneficial effect of the intervention on adherence. We found that interventions targeting practical medication management skills, those administered to individuals vs groups, and those interventions delivered over 12 weeks or more were associated with improved adherence outcomes. We also found that interventions targeting marginalized populations such as women, Latinos, or patients with a past history of alcoholism were not successful at improving adherence. We were unable to determine whether effective adherence interventions were associated with improved virological or immunological outcomes. Most studies had several methodological shortcomings leaving them vulnerable to potential biases. AUTHORS' CONCLUSIONS: We found evidence to support the effectiveness of patient support and education interventions intended to improve adherence to antiretroviral therapy. Interventions targeting practical medication management skills, those interventions administered to individuals vs groups, and those interventions delivered over 12 weeks or more were associated with improved adherence outcomes. There is a need for standardization and increased methodological rigour in the conduct of adherence trials.


Subject(s)
Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , Patient Compliance , Patient Education as Topic , Acquired Immunodeficiency Syndrome/drug therapy , Humans , Pharmacies , Randomized Controlled Trials as Topic
14.
Aging Ment Health ; 10(1): 27-32, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16338811

ABSTRACT

The present pilot study investigated the pattern of neuropsychological functioning associated with the presence of delusions in mild-to-moderate dementia. Participants, all of whom met criteria for dementia, were divided into two groups, delusional (n = 9) and non-delusional (n = 9). Individuals with hallucinations were excluded. Participants completed a neuropsychological test battery. Global cognitive functioning (MMSE) and behavioral disturbance (BEHAVE-AD) were also assessed. Differences between the delusional and non-delusional group were most marked for immediate recall of stories, which was higher in the non-delusional group. Scores on semantic fluency, attention (mental control), and overall cognitive functioning (MMSE) were also lower in the delusional group. Conversely, simple attention span (Digit Span) was within normal limits in both groups. Floor effects were noted on measures of delayed recall and alternating attention. This study supports previous findings of greater neuropsychological impairment in delusional as compared to non-delusional individuals with dementia. However, some areas of cognitive functioning may be relatively preserved. Future research should examine semantic processing in persons with dementia with and without delusions.


Subject(s)
Delusions/psychology , Dementia , Neuropsychological Tests , Aged , Aged, 80 and over , Cognition , Comorbidity , Female , Humans , Male , Mental Recall , Ontario , Pilot Projects
15.
Can J Neurol Sci ; 28(3): 228-31, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11513341

ABSTRACT

BACKGROUND: Neurocognitive impairment is a frequent complication of HIV infection and heralds a poor survival prognosis. With the availability of highly active antiretroviral therapy (HAART), survival times for HIV-infected patients have markedly increased although the effects of HAART on the prevalence of neurocognitive impairment remain uncertain. OBJECTIVE: To determine the relationship between self-reported neurocognitive symptoms and neuropsychological (NP) performance together with the impact of HAART among HIV-infected patients. METHODS: A cross-sectional study was performed in which patients without previously documented neurocognitive impairment attending an HIV community clinic were questioned about neurocognitive symptoms and a NP test battery was administered. RESULTS: Of the eighty-three patients examined, neurocognitive symptoms were reported by 34% of patients and were associated with a shorter duration of HAART and higher viral loads. Patients reporting neurocognitive symptoms were also more likely to exhibit impaired NP performance (p<0.005) with NP impairment being detected in 46% of all patients examined (12% with HIV-associated dementia). Neuropsychological impairment was directly correlated with age (p<0.001), plasma viral load (p<0.005) and inversely correlated with the number of prescribed antiretroviral drugs (p<0.01). CONCLUSIONS: These results suggest that neurocognitive symptoms are predictive of impaired NP performance and that NP impairment remains a frequent finding among older patients with higher viral loads. An increased number of antiretroviral drugs may be neuroprotective.


Subject(s)
Cognition Disorders/etiology , Cognition Disorders/psychology , HIV Infections/complications , HIV Infections/psychology , Adult , Aged , Community Health Services , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Neuropsychological Tests
16.
J Int Neuropsychol Soc ; 5(3): 234-46, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10217923

ABSTRACT

UNLABELLED: To explore how age and length of abstinence affects neuropsychological (NP) recovery in chronic male alcoholics, we examined 97 recently detoxified alcoholics (RDA) who were abstinent a mean of 29.7 (SD = 9.4) days at their first evaluation, and again 2 years later, at which time 62 had resumed drinking (RES) and 35 had maintained interim abstinence (ITA). To separate practice effects from NP recovery, the NP performance of the RES and ITA groups were compared to age- and education-matched 29 long-term abstinent (LTA) alcoholics, abstinent a mean of 4.3 (SD = 3.5) years at initial testing, and 49 nonalcoholic controls (NAC). Sample mean age and education was 48.7 (SD = 8.8) and 13.9 (SD = 2.7) years, respectively. The RDA and LTA groups were also matched on years of alcoholic drinking [i.e., 17.2 (SD = 9.3) and 15.6 (SD = 8.7) years respectively]. Results of 14 NP tests were reduced to 6 NP abilities (i.e., attention learning, memory (recall), abstraction-cognitive flexibility, complex perceptual-motor integration and simple motor skills) that formed dependent variables in 4 groups x 2 ages (median split at 51.4 years classified participants as young and old) repeated measures MANOVA. RESULTS: (1) the ITA group improved on abstracting ability more than other groups (p = .009) (2) the RES group deteriorated on motor tests (p = .03); (3) all younger alcoholics exceeded practice effects on abstracting ability, while older RES participants deteriorated relative to ITA group (3-way interaction, p = .03); and (4) the LTA group was comparable in NP performance to the NAC group. In conclusion, the extent and features of NP recovery among alcoholics are related to age, length of abstinence, and interim drinking.


Subject(s)
Alcohol Drinking/prevention & control , Alcoholism/complications , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Convalescence/psychology , Temperance/psychology , Adult , Age Factors , Alcoholism/psychology , Follow-Up Studies , Humans , Male , Middle Aged , Neuropsychological Tests , Time Factors
17.
J Clin Exp Neuropsychol ; 21(6): 737-56, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10649531

ABSTRACT

We examined the degree to which depressive symptoms, clinical staging of HIV disease, and neuropsychological (NP) functioning were related to neurocognitive complaints in HIV-infection. One hundred adults with HIV-infection (12 asymptomatic, 41 mildly symptomatic, and 47 with AIDS) were administered NP tests of attention and working memory, language, psychomotor speed, verbal memory, and conceptual problem-solving, the Beck Depression Inventory, and the Patient's Assessment of Own Functioning Inventory (Chelune, Heaton & Lehman, 1986), a subjective neurocognitive complaint questionnaire where patients rated their problems with memory, language and communication, sensory-motor skills, and higher-level cognitive and intellectual functions. Neurocognitive complaints (regardless of specific type) were correlated significantly with depressive symptoms and with NP measures of attention and working memory, psychomotor skills, and learning efficiency. However, multiple regression analyses revealed that depressive symptoms accounted for the majority of variance explained in neurocognitive complaints with psychomotor efficiency generally predicting the remaining variance. Neurocognitive complaints did not differ according to HIV clinical staging.


Subject(s)
Cognition Disorders/virology , Depression/virology , HIV Infections/complications , Psychomotor Performance , Acquired Immunodeficiency Syndrome/complications , Adult , CD4 Lymphocyte Count , Cognition Disorders/psychology , Depression/psychology , Female , HIV Infections/psychology , Humans , Male , Middle Aged , Multivariate Analysis , Neuropsychological Tests , Psychiatric Status Rating Scales , Self-Assessment , Severity of Illness Index
18.
J Clin Exp Neuropsychol ; 21(6): 757-68, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10649532

ABSTRACT

Ninety-one adults with HIV-infection who varied in the concordance between their subjective memory complaints (or metamemory) on the Patient's Assessment of Own Functioning (Chelune, Heaton, & Lehman, 1986) and their memory performance on the California Verbal Learning Test (CVLT), were compared on the Beck Depression Inventory (BDI), and on neuropsychological (NP) tests of attention, language, psychomotor speed, and conceptual problem-solving. Subjects with low memory complaints and normal CVLT performance (n = 29) had low BDI scores and were normal in all other NP abilities. Subjects with high memory complaints and impaired CVLT performance (n = 20) had elevations on the BDI as well as NP impairments in psychomotor speed and category fluency. Subjects with low memory complaints but impaired CVLT performance (n = 16) had low BDI scores and were selectively impaired in conceptual problem-solving. Subjects with high memory complaints but normal CVLT performance (n = 26) had high BDI scores and normal NP functioning in all other abilities. These results suggest that there are at least two key determinants to metamemory inaccuracy in HIV-infection, namely, frontal executive impairments and mood disturbance.


Subject(s)
Cognition , Depression/virology , HIV Infections/complications , Memory Disorders/virology , Memory , Acquired Immunodeficiency Syndrome/complications , Adult , Analysis of Variance , CD4 Lymphocyte Count , Depression/psychology , Female , HIV Infections/psychology , Humans , Individuality , Male , Memory Disorders/psychology , Middle Aged , Neuropsychological Tests , Self-Assessment , Severity of Illness Index
19.
J Stud Alcohol ; 59(6): 640-6, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9811085

ABSTRACT

OBJECTIVE: The goals of this study were to examine the hazard of relapse during an average 11 years of follow-up in alcoholics who had achieved long-term abstinence and to determine predictors of later relapse. METHOD: Male alcoholics (N = 77) with at least 18 months of stable abstinence at time of entry were followed for 2 to 17 years (mean follow-up = 10.9 years). During follow-up, detailed information regarding relapse/abstinence and interim drinking behavior was recorded. Potential predictors of relapse collected at enrollment included past drinking history, severity of alcohol-related life problems, degree of neurocognitive impairment based on neuropsychological (NP) tests, psychological distress (MMPI) and past medical health. RESULTS: Twenty-four of 77 (31%) long-term abstainers relapsed during the follow-up period. The average annual hazard rate of relapse was 3.8% in the first 5 years of follow-up and 2.6% over the next 6-11 years. Based on Cox proportional hazard regression analyses, the only significant variables to predict relapse were MMPI Scale 4 (Psychopathic Deviate, relative risk = 3.16, 95% CI = 1.19-8.38) and prior history of alcohol-related life difficulty (i.e., citation for driving while intoxicated, relative risk = 2.64, 95% CI = 1.05-6.64) (chi2 = 14.2, 2 df, p < .001). CONCLUSIONS: There is approximately a 3% annual risk of relapse in alcoholics who have been able to achieve long-term abstinence, even after 5 years of abstinence. Alcoholics who resumed drinking had greater indicators of longer standing psychological trait disturbance, reflected in elevated MMPI Scale 4 and history of more alcohol-related social difficulties. Placing the present study in the context of previous research that focused primarily on predictors or relapse in the shorter term, it appears that, whereas mood disturbance predicts short-term outcome, more enduring personality traits predict long-term success in remaining abstinent.


Subject(s)
Alcoholism/diagnosis , Temperance , Adult , Alcoholism/classification , Alcoholism/complications , Alcoholism/psychology , Cognition Disorders/complications , Follow-Up Studies , Humans , Male , Middle Aged , Personality , Prognosis , Recurrence , Social Adjustment , Statistics as Topic , Temperance/psychology , Temperance/statistics & numerical data , Time Factors
20.
Percept Mot Skills ; 84(2): 403-14, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9106827

ABSTRACT

Some previous studies have suggested that alcoholics exhibit selective right-hemisphere dysfunction, based on alcoholics' poor performance on tests believed to subserve the right hemisphere. However, some of these experiments did not account adequately for differences in difficulty or novelty in putative right hemisphere tasks. This experiment was designed to evaluate and compare intermanual differences in grip strength, motor speed, fine-motor dexterity, and nonverbal problem-solving ability in 93 recently detoxified alcoholics, 54 long-term abstinent alcoholics, and 73 nonalcoholic controls. All subjects were right-handed men, matched for age and education, and both alcoholic groups had similar drinking histories. Using percent difference scores to assess intermanual differences, adjusted for demographics where appropriate, we found that, although recently detoxified alcoholics demonstrate some motor and psychomotor impairments, there is no evidence using these tests to suggest the right hemisphere is selectively more vulnerable to the effects of chronic alcohol abuse.


Subject(s)
Alcoholism/diagnosis , Brain/physiopathology , Functional Laterality , Neuropsychological Tests , Psychomotor Performance , Adult , Alcoholism/physiopathology , Functional Laterality/physiology , Hand Strength/physiology , Humans , Male , Motor Skills/physiology , Muscle Contraction/physiology , Physical Exertion/physiology , Psychomotor Performance/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...